Get the Stockscreener App
6.00
5.08%
0.29
After Hours:
6.11
0.11
+1.83%
Aldeyra Therapeutics Inc Stock (ALDX) Latest News
Aldeyra Therapeutics (NASDAQ:ALDX) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Short Interest in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Grows By 8.2% - MarketBeat
Exclusive Fireside Chat: Aldeyra CEO Reveals Company Strategy at Major Healthcare Conference - StockTitan
Aldeyra Therapeutics (NASDAQ:ALDX) Shares Pass Below 200-Day Moving AverageHere's What Happened - MarketBeat
Dry Eye Disease Market to Observe Stupendous Growth by 2034 | DelveInsight - The Malaysian Reserve
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price Crosses Below 200-Day Moving Average – Here’s Why - Defense World
ALDX (Aldeyra Therapeutics) Cash-to-Debt : 7.22 (As of Sep. 2024) - GuruFocus.com
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Up 8.2% in December - Defense World
Is Aldeyra Therapeutics (ALDX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks - Insider Monkey
Barclays PLC Acquires 48,313 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
Jane Street Group LLC Has $128,000 Stock Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
International Assets Investment Management LLC Has $312,000 Stock Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Bought by Barclays PLC - Defense World
Geode Capital Management LLC Has $6.01 Million Holdings in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
3 US Penny Stocks With Market Caps Over $80M To Watch - Simply Wall St
State Street Corp Purchases 16,188 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
Aldeyra Therapeutics (NASDAQ:ALDX) Stock Crosses Below 50 Day Moving AverageTime to Sell? - MarketBeat
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation - The Bakersfield Californian
Aldeyra, UnitedHealth Group Incorporated, Blue Ridge - GlobeNewswire
Aldeyra Therapeutics: Key Inflection Point Ahead (NASDAQ:ALDX) - Seeking Alpha
4 Stock-ing Stuffers for Under $10 a Share - TheStreet
High Growth Tech Stocks To Watch In December 2024 - Simply Wall St
BNP Paribas Financial Markets Acquires 10,201 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Sold by Verition Fund Management LLC - MarketBeat
Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock? - MSN
Aldeyra stock retains Outperform rating on strong DED drug outlook By Investing.com - Investing.com Australia
Aldeyra stock retains Outperform rating on strong DED drug outlook - Investing.com
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Short Interest Down 12.3% in November - Defense World
Short Interest in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Drops By 12.3% - MarketBeat
Objective long/short (ALDX) Report - Stock Traders Daily
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Purchased by Jacobs Levy Equity Management Inc. - MarketBeat
Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Sees Large Increase in Short Interest - MarketBeat
Aldeyra Therapeutics CEO to Present at Citi Healthcare Conference Ophthalmology Panel - StockTitan
Final Deadline Alert: ALDX Investor Alert: Contact Bronstein, Ge - GuruFocus.com
Eagle Asset Management Inc. Lowers Stock Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - MarketBeat
ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap - MSN
Aldeyra announces FDA acceptance of resubmitted reproxalap application - MSN
Top US Penny Stocks To Watch In November 2024 - Simply Wall St
Perceptive Advisors buys 200,000 shares of Aldeyra Therapeutics Inc's common stock on Sept 19 - Reuters.com
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):